Valuation

AVAHAveanna Healthcare Holdings Inc.

StockNasdaqUnited StatesHealth careEU retail: available

+2.8% today · +33.1% over a year

5/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 83% of the instruments we score

Priced lower than most peers. No dividend.

Aveanna Healthcare Holdings Inc. (AVAH) valuation against sector peers: P/E 10.4 (sector median 30.6), P/B 9.9, EV/EBIT 14.8, P/S 1.1.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricAVAHSector medianvs median
P/E10.430.6 · n=15266% below
P/B9.94.0 · n=305148% above
P/S1.14.4 · n=29775% below
EV/EBIT14.825.8 · n=13943% below
Free-cash-flow yield—1.4% · n=287—
Dividend yield0.00%0.00% · n=358—
Return on equity95.6%−3.7% · n=306—
Return on invested capital20.6%0.4% · n=2754,632% above
Gross margin32.3%61.7% · n=20248% below
Net debt / EBITDA4.211.31 · n=146221% above

Value factor: 88 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

LLYEli Lilly & Co45.435.8—1.5%0.6%7/10
JNJJohnson & Johnson40.58.0—3.2%1.9%8/10
ABBVAbbVie80.6—33.83.6%3.0%5/10
UNHUnitedHealth25.93.519.16.5%2.2%9/10
MRKMerck109.68.3—4.6%2.4%9/10
TMOThermo Fisher Scientific37.44.936.72.8%0.3%10/10
AMGNAmgen27.920.925.24.2%2.2%7/10
GILDGILEAD—16.7—6.6%2.0%5/10
ABTAbbott28.43.426.84.1%3.0%6/10
PFEPfizer38.72.0—6.5%7.3%1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 04 Jul 2026 · filed 13 Aug 2026